Business
MDCorp Enters $450 Million European Endoscope Systems Sales Market
MDCorp Enters $450 Million European Endoscope Systems Sales Market.
About this update from Qian Yuan Baixing, Inc.
[{"type":"text","content":"\n\n\n\nMDCorp Enters $450 Million European Endoscope Systems Sales Market\n\n/* Style Definitions */\nspan.prnews_span\n{\nfont-size:8pt;\nfont-family:\"Arial\";\ncolor:black;\n}\na.prnews_a\n{\ncolor:blue;\n}\nli.prnews_li\n{\nfont-size:8pt;\nfont-family:\"Arial\";\ncolor:black;\n}\np.prnews_p\n{\nfont-size:0.62em;\nfont-family:\"Arial\";\ncolor:black;\nmargin:0in;\n}\n\n\n\n\n\n\nMDCorp Enters $450 Million European Endoscope Systems Sales Market\nPR Newswire\nSEATTLE, July 31, 2017\n\n\n\nSEATTLE, July 31, 2017 /PRNewswire/ -- MDCorp $MDCX has executed a distribution agreement with Smart Endoscope Systems allowing MDCorp to sell the G-Eye product portfolio throughout their six core European markets.\n\nNeuraxon, currently under M&A with MDCorp is charged with distributing the G-Eye system throughout Europe and their network of 92 hospitals.\n\nMr. Pantelis Stanitsas stated: \"This kind of product distribution win is what we have expected from our M&A partner MDCorp.  This win with Smart Endoscope Systems serves to further bind our two companies and our intended M&A which is currently in the process of enhanced due diligence.  The G-Eye system should be sold through to our base of 92 hospitals covering an addressable market of 100 million people in six countries.  Endoscope related sales in our markets total some $450 million USD annually, and we are particularly enthusiastic about deployment of the new, world class, patented, life-saving technology.\"\n\nOnsite product training is set to begin in September/October in Israel.\n\nMDCorp seeks to expand into current and new markets, open new branch offices and expand sales, layering more products and services through existing and then new sales channels.\n\nInquiries:  [email protected] \n\nForward-Looking Statements\n\nThis press release contains \"forward-looking statements\" within the meaning of the \"safe harbor\" provisions of the Private Securities Litigation Reform Act of 1995, including but not limited to, statements regarding the MDCorp's position as a market leader, acceleration of innovation and expansion of total addressable market opportunity.  These forward-looking statements are made as of the date they were first issued and were based on current expectations, estimates, forecasts and projections as well as the beliefs and a...